“Young Blood” – The Emerging Market for Products Made from the Blood of Children
Last year, we brought to the attention of our readers the growing market for "young blood," and products derived from the blood of children and young people, when Netflix launched their new show in August of 2020 called “Biohackers.” We also reported how the drug "adrenochrome," harvested from terrorized young children who produce blasts of adrenalin, including children murdered in Satanic Ritual Abuse, was beginning to get mainstream media coverage outside the U.S. back in 2020. While the corporate media in the U.S. would like to ignore and censor anything related to adrenochrome, "young blood" is a concept that they apparently want to bring mainstream and condition the public to accept. So it was no surprise that Newsweek ran a major article on "young blood" last week, which was mainly positive and tried to present drug research into making products from "young blood" as "scientific" and inevitable. There is even an official "scientific" name for this research now: "geroscience." Geroscience "seeks to understand molecular and cellular mechanisms that make aging a major risk factor and driver of common chronic conditions and diseases of older adulthood," according to the National Institutes of Health. The admitted "problem" with developing these drugs derived from the blood of children and young adults, is where to get it.